Clinical trial
Hydroxyurea and Transfusion: Pilot Study of Combination Therapy for Patients With Sickle Cell Anemia
NCT03644953 is registered in ClinicalTrials.gov with Children's National Research Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Hydroxyurea and Transfusion: Pilot Study of Combination Therapy for Patients With Sickle Cell Anemia
- Lead sponsor
- Children's National Research Institute
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- October 30, 2018
- Completion date
- July 1, 2021
- Enrollment
- 14 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
sickle cell disease